Neff T A, Fischer J E, Schulz G, Baenziger O, Weiss M
Department of Intensive Care and Neonatology, University Children's Hospital, Zurich, Switzerland.
Intensive Care Med. 2001 Jan;27(1):287-91. doi: 10.1007/s001340000784.
To evaluate the effect of different infusion pump models on continuity of drug delivery during vertical displacement of syringe pumps.
Zero-drug delivery time (ZDDT), retrograde aspiration volume, and infusion bolus were recorded using the same syringe in three different models of syringe pump after lowering and elevating the pump. Compliance of each infusion assembly was measured using the occlusion release technique at 38 mmHg.
Lowering the pump by 50 cm at an infusion rate of 1 ml/h resulted in ZDDT values ranging from 2.78 +/- 0.29 to 5.99 +/- 1.09 min. Elevating the syringe pump to its original position caused infusion boluses between 44.1 +/- 3.2 and 77.1 +/- 5.1 microl. The results demonstrated that there are large differences between syringe pump models (F = 66.8, df = 2/33, p < 0.0001) and between pumps of the same model (F = 21.3, df = 1/34, p < 0.0001). A similar pattern was found in retrograde aspiration volume and infusion bolus.
All tested pumps led to clinically relevant flow irregularities during vertical displacement of the syringe pump. Thus, vertical displacement of any syringe pump connected to an infusion line delivering highly potent drugs at low infusion rates should be avoided. The variability across syringe pumps indicates that syringe pump design remains an area of potential further improvement for reducing the risk of adverse patient events.
评估不同输液泵型号在注射泵垂直移位过程中对药物输送连续性的影响。
在三种不同型号的注射泵中,使用同一注射器在泵下降和上升后记录零药物输送时间(ZDDT)、逆行抽吸量和输注推注量。在38 mmHg压力下,采用闭塞释放技术测量每个输液组件的顺应性。
以1 ml/h的输注速率将泵下降50 cm时,ZDDT值范围为2.78±0.29至5.99±1.09分钟。将注射泵提升至其原始位置会导致44.1±3.2至77.1±5.1微升的输注推注量。结果表明,注射泵型号之间存在很大差异(F = 66.8,自由度 = 2/33,p < 0.0001),同一型号的泵之间也存在差异(F = 21.3,自由度 = 1/34,p < 0.0001)。在逆行抽吸量和输注推注量中也发现了类似的模式。
在注射泵垂直移位过程中,所有测试的泵都会导致临床上相关的流量不规则。因此,应避免任何连接到以低输注速率输送强效药物的输液管线上的注射泵发生垂直移位。注射泵之间的变异性表明,注射泵设计仍是降低患者不良事件风险的一个有潜在进一步改进空间的领域。